7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Atherosclerosis D050197 85 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Arteriosclerosis D001161 86 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Brain Ischemia D002545 89 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Insulin Resistance D007333 99 associated lipids
Weight Gain D015430 101 associated lipids
Glioma D005910 112 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Yano S et al. Static and dynamic hypergravity responses of osteoblasts and osteoclasts in medaka scales. 2013 Zool. Sci. pmid:23480382
Zhang XM et al. [Adiponectin regulates the expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand in human osteoblast]. 2008 Zhonghua Yi Xue Za Zhi pmid:18956641
Xiao XH et al. [Ascorbic acid inhibits the formation and function of osteoclasts from RAW264.7 cells induced by receptor activated nuclear factor kappaB ligand in vitro]. 2004 Zhonghua Yi Xue Za Zhi pmid:15730627
Wang C et al. [Osteoprotegerin gene polymorphism and therapeutic response to alendronate in postmenopausal women with osteoporosis]. 2009 Zhonghua Yi Xue Za Zhi pmid:20137703
Wang M et al. [Bone mass change and its possible mechanisms in murine knockout apolipoprotein E(ApoE-/-)]. 2009 Zhonghua Yi Xue Za Zhi pmid:20137704
Zhong N et al. [Relationship between polymorphism of parathyroid hormone and bone mineral density and relevant biochemical indicators in women]. 2006 Zhonghua Yi Xue Za Zhi pmid:16677544
Cheng Q et al. [Effect of osteoprotegerin gene polymorphism on bone mass in postmenopausal women]. 2004 Zhonghua Yi Xue Za Zhi pmid:15059506
Xiang GD et al. [Changes of osteoprotegerin before and after insulin therapy in type 1 diabetic patients]. 2007 Zhonghua Yi Xue Za Zhi pmid:17686254
Fang TY et al. [Serum osteoprotegrin and serum bone gamma-carboxyglutamine acid-containing protein are correlated with bone mineral density in normal women]. 2004 Zhonghua Yi Xue Za Zhi pmid:15569454
Sun CX et al. [Patterns of osteoprotegerin or nuclear factor kappa B ligand gene expression in the treatment of bone defect with bone marrow stem cell transplantation and low-frequency vibration]. 2011 Zhonghua Yi Xue Za Zhi pmid:21600122

Table of Content